Neliva

JNJJohnson & Johnson

HealthcareUpdated 2026-04-24
$227.50-1.37%
Open
$229.03
High
$229.99
Low
$227.02
Volume
6.1M
Market Cap
$548.25B
P/E Ratio
26.06
P/B Ratio
6.75
Enterprise Value
$581.19B

Get AI-Powered Analysis of JNJ

Neliva uses real-time data and AI to provide deep research on Johnson & Johnson — including fundamentals, risk assessment, earnings review, and actionable insights.

Free to try — no account required for your first research.

About Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ) is a publicly traded company in the Healthcare sector, listed as a component of the S&P 500 index. With a market capitalization of $548.25B, it is one of the significant players in its industry. The stock currently trades at a price-to-earnings ratio of 26.06.

Investors and analysts track JNJ for its performance within the Healthcare sector. Using Neliva's AI-powered research tools, you can get comprehensive analysis including real-time pricing, fundamental analysis, technical indicators, news sentiment, and risk assessment — all in seconds.

Frequently Asked Questions

What is the current price of JNJ?
As of 2026-04-24, JNJ is trading at $227.50 (-1.37% today). Range: $227.02 — $229.99.
What is the P/E ratio of JNJ?
JNJ has a P/E ratio of 26.06, helping assess valuation relative to earnings.
Is JNJ a good stock to buy?
Whether JNJ is a good investment depends on your goals and risk tolerance. Neliva’s AI provides comprehensive analysis including valuation, growth, risk factors, and analyst consensus.
What sector is JNJ in?
Johnson & Johnson (JNJ) is in the Healthcare sector of the S&P 500.

Related Healthcare Stocks

Research any stock with AI

Get real-time data, fundamental analysis, risk assessment, and actionable insights — powered by AI.

Get started free